From personalized to precision cancer medicine

Evangelos G Baltagiannis; Ioannis D Kyrochristos; Demosthenes E Ziogas; Anna Goussia; Michail Mitsis; Dimitrios H Roukos

doi:10.2217/pme-2020-0056

From personalized to precision cancer medicine

Per Med. 2020 Jul 1;17(4):245-250. doi: 10.2217/pme-2020-0056. Epub 2020 Jun 26.

Authors

Evangelos G Baltagiannis^{1

2}, Ioannis D Kyrochristos^{1

2}, Demosthenes E Ziogas^{1

3}, Anna Goussia⁴, Michail Mitsis^{2

5}, Dimitrios H Roukos^{1

2

6}

Affiliations

¹ Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, Greece.
² Department of Surgery, University Hospital of Ioannina, Ioannina, Greece.
³ Department of Surgery, 'G. Hatzikosta' General Hospital, Ioannina, Greece.
⁴ Department of Pathology, University Hospital of Ioannina, Ioannina, Greece.
⁵ Cancer Biobank Centre, Ioannina University, Ioannina, Greece.
⁶ Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.

PMID: 32589113
DOI: 10.2217/pme-2020-0056

No abstract available

Keywords: cancer precision medicine; combinatorial therapies; genome; genome engineering; intratumor heterogeneity; next-generation sequencing; predictive biomarkers; regulatory networks; single-cell sequencing; transcriptome.

Publication types

Editorial

MeSH terms

Cell-Free Nucleic Acids / genetics
Humans
Neoplasms / genetics*
Neoplasms / therapy*
Precision Medicine / methods
Precision Medicine / trends*

Substances

Cell-Free Nucleic Acids